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Abstract
Objectives—The Cutaneous Assessment Tool (CAT) is a comprehensive, semi-quantitative tool
for the assessment of skin disease in juvenile dermatomyositis (DM). The goal of this study was to
determine if alternative scoring methods would shorten the CAT, and potentially its completion time,
without compromising its measurement characteristics.
Methods—One hundred and thirteen children with juvenile DM were assessed at baseline; 94 were
assessed again 7–9 months later. Inter-rater reliability, internal consistency, construct validity and
responsiveness were obtained using the Original scoring method and 2 alternative methods: the
Maximum and Binary scoring methods.
Results—Spearman’s correlations of the Maximum and Binary methods with the Original method
were both 0.98 (P < 0.0001) for the CAT activity score and 0.96 and 0.98 respectively (P < 0.0001)
for the CAT damage score. Values obtained for inter-rater reliability, internal consistency, construct
validity and responsiveness were similar for all 3 scoring methods of the CAT. Although there was
a trend towards the Maximum method having a higher inter-rater reliability, and the Binary method
having a higher responsiveness, the confidence intervals were widely overlapping, and no statistically
significant differences were observed. Correlations of the 3 scoring methods with other measures of
skin disease activity and damage used to assess construct validity were virtually identical.
Conclusions—The Maximum and Binary methods of scoring the CAT have measurement
characteristics similar to the Original method, while potentially reducing the time to administer the
tool. Adoption of one of these scoring methods should increase acceptability to clinicians and
researchers.
Muscle disease, expressed as weakness, poor endurance and impaired function, is the dominant
feature of juvenile dermatomyositis (DM). However cutaneous involvement is also an
important manifestation of both disease activity and disease damage, is an significant source
of morbidity, and is associated with poorer outcomes [1,2]. For these reasons, skin disease
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activity and damage are essential components of the overall assessment of children with
juvenile DM.
We have previously described the Cutaneous Assessment Tool (CAT), a comprehensive, semi-
quantitative tool for assessing skin disease activity and damage in children with juvenile
idiopathic inflammatory myopathy [3]. We have shown that the CAT has appropriate
reliability, construct validity and sensitivity to change, and is a promising tool for use in clinical
and research contexts [3,4].
In the development of the CAT, the investigators had the explicit goal of including all of the
skin lesions that were important in the assessment of juvenile DM. Detailed descriptions were
included for each lesion and each lesion was further sub-divided by characteristics, such as
erythema, scaling or ulceration, in order to generate different levels of severity of skin disease
activity or damage for each one. Individual lesions and their gradations of severity were
assigned weights based on expert opinion of the importance of those features in the assessment
of skin disease activity and damage. Although this resulted in a tool that was 8 pages long and
quite complex, it was felt that this was necessary to reflect the complexity of the construct
being measured. However, the CAT has been criticized for this length and complexity, leading
to reconsideration of trying to simplify the tool.
The goal of this study was to evaluate the use of alternative scoring methods for the CAT.
Specifically, we were interested in determining if alternative scoring methods would shorten
the CAT, and potentially its completion time, without compromising its measurement
characteristics.
Patients and Methods
Patients
This study involved reanalysis of data previously obtained [3,4], and did not involve the study
of new patients. One hundred and thirteen children with definite or probable juvenile DM [5]
were enrolled in this study. They were seen by 11 assessors at 10 tertiary-care pediatric
institutions at baseline. Ninety-four were assessed again 7 – 9 months later. At one center, 17
children were seen by both a pediatric rheumatologist and a dermatologist within 48 hours of
each other. Approval from local institutional review boards was obtained at each center, and
consent was obtained from parents or legal guardians of all participants.
The characteristics of this cohort have previously been described [6–8]. In brief, children were
enrolled consecutively at participating centers at any point in their disease course. At the
baseline visit, the median disease duration was 19 months [25th % 8 months, 75th % 33 months]
and median global disease activity and damage were 2.1 cm [25th % 0.6 cm, 75th % 4.3 cm]
and 1.2 cm [25th % 0 cm, 75th % 1.5 cm] on 10 cm visual analogue scales (VAS), respectively.
All study participants were evaluated as previously described [3,4]. These assessments
included history, physical examination, physician global assessments of disease and skin
disease activity and damage (separate 10 cm VAS for all global assessments) [6], the Childhood
Myositis Assessment Scale (CMAS) [8,9], the Childhood Health Assessment Questionnaire
(CHAQ) [7], and Manual Muscle Testing (MMT) [7].
The CAT
In addition to the above, each study participant was evaluated with the CAT. Briefly, the CAT
is 21-item tool with 10 items assessing skin disease activity, 4 items assessing skin disease
damage and 7 items which separately assess both skin disease activity and damage, as
previously reported [3]. Each item of the CAT has a specific definition and description of the
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characteristics to be assessed. There are 2 – 7 response categories for each item, representing
different degrees of skin disease activity or damage, to which a priori weighted scores are
assigned. The scores for individual activity and damage items are summed to give the CAT
activity score (potential range 0 – 96) and the CAT damage score (potential range 0 – 20).
Higher scores correspond to greater activity and damage.
Alternative Scoring of the CAT
The scoring method described above, the Original Method, was compared to 2 alternative
scoring methods. In the first, called the Maximum method, all items were assessed as present
or absent. If an item was present, it received the maximum possible score for that item under
the Original method. The activity and damage items were summed as in the Original method
to give the Maximum CAT activity (potential range 0 – 96) and damage (potential range 0 –
20) scores. In the second alternative scoring method, called the Binary method, all items were
also assessed as being present (scored 1) or absent (scored 0). The activity and damage items
were summed to give the Binary CAT activity (potential range 0 – 17) and damage (potential
range 0 – 11) scores.
Analysis
All analyses were performed using the statistical programs SAS (Release 8.02, SAS Institute
Inc, Cary NC) and Stata (Intercooled Stata 9.2 for Windows, StataCorp, College Station, TX).
Descriptive statistics were used including medians and Spearman’s correlation coefficient
where appropriate. Measurement characteristics for the Original method of scoring the CAT
have been reported previously [3,4].
In order to assess inter-rater reliability of the 3 scoring methods, the intra-class correlation
coefficients (ICC) were calculated for the CAT activity and damage scores for the Maximum
and Binary methods and compared to the values for the Original method [3]. Confidence
intervals were calculated [10].
Internal consistency was assessed with Cronbach’s alpha, calculated for the total scores, and
with each item deleted serially from the total score. Cronbach’s alpha was calculated using
standardized variables. Confidence intervals were calculated using the BOOTSTRAP function
of Stata, with 1000 iterations to determine each value.
Construct validity of the alternative CAT scoring methods was assessed by calculating
Spearman’s correlations between the CAT activity scores obtained from the 3 scoring methods
and other measures of disease activity (physician global disease activity, physician global skin
disease activity, the CMAS, the CHAQ and MMT). This was repeated for the CAT damage
scores obtained from the 3 scoring methods and other measures of disease damage (physician
global disease damage, physician global skin disease damage, the CMAS, the CHAQ and
MMT).
Responsiveness was assessed by calculating the standardized response mean (SRM) [11] for
all children with data at two assessments (N = 94). The SRM for the Maximum and Binary
method CAT activity and damage scores were compared to values for the Original method.
Confidence intervals were calculated [11].
Power
A post hoc power analysis was conducted using the values for the original CAT activity score
in order to explore the ability of this study to detect differences in some of the measurement
characteristics assessed. For the ICC’s, there was an estimated power of 52% to detect a
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difference of 0.1 and 55% to detect a difference of 0.2. For Cronbach’s alpha, there was an
estimated power of 63% to detect a difference of 0.10 and 75% to detect a difference of 0.20.
Results
Baseline CAT activity and damage scores based on the Original, Maximum and Binary
methods are presented in Table 1. The Spearman’s correlations of the Maximum and Binary
method CAT activity scores with the Original CAT activity score were both 0.98 (P < 0.0001).
The Spearman’s correlations of the Maximum and Binary method CAT damage score with the
Original CAT damage score were 0.96 and 0.98 respectively (P < 0.0001).
Inter-rater reliability
As shown in Table 1, the ICC’s for the Original, Maximum and Binary CAT activity scores
ranged from 0.60 – 0.70, and from 0.65 – 0.80 for the Original, Maximum and Binary CAT
damage scores. The 95% confidence intervals were widely overlapping.
Internal consistency
The Cronbach’s alpha values for Original, Maximum and Binary CAT activity scores and the
Original, Maximum and Binary CAT damage scores are summarized in Table 1.
Construct validity
Spearman’s correlations used to compare construct validity of the 3 scoring methods are shown
in Table 2.
Responsiveness
The SRM for the Original, Maximum and Binary CAT activity scores and the Original,
Maximum and Binary CAT damage scores are summarized in Table 1. The values for the CAT
damage score are expected to be low due the time course of the study.
Discussion
In this paper we have compared 3 methods of scoring the CAT. We have shown that the
alternative scoring methods have similar measurement characteristics to the Original scoring
method, including inter-rater reliability, internal consistency, construct validity and
responsiveness.
For intra-rater reliability, both alternative scoring methods appeared to have somewhat lower
ICC’s for the CAT activity score and a lower ICC for the Binary CAT damage score. However,
the 95% confidence intervals for the ICC’s of all 3 methods were widely overlapping, and no
significant difference in inter-rater reliability was observed. Internal consistency, as measured
by Cronbach’s alpha, showed a trend towards the alternative scoring methods having slightly
lower values. Again, the 95% confidence intervals were widely overlapping, and no significant
difference was observed. The correlations of the CAT activity and damage scores with other
measures of disease activity or damage were essentially indistinguishable for the different
scoring methods. Finally, the SRMs calculated to assess responsiveness were similar for each
of the scoring methods. There was a trend for the SRMs of the Binary method to have somewhat
higher values, but with the widely overlapping confidence intervals, no significant difference
was observed.
Taken together these results fail to document superiority of any of these scoring methods. This
is not surprising, given that it has been shown that changes in weighting of items do not typically
affect the measurement characteristics of tools like the CAT [12]. Thus we conclude that each
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of these scoring methods is likely to perform similarly. However, both alternative scoring
methods simplify the CAT, and it is reasonable to adopt one of these. There is not a clear choice
as to which alternative to choose. The Binary scoring method showed a trend towards better
responsiveness, while the Maximum method showed a trend towards better inter-rater
reliability. The Binary method results in the simplest CAT, where the assessor does not need
to remember what score a particular lesion receives, while the Maximum method maintains
the weighting of the Original method, and may appear to assessors to be more sensible, as it
assigns larger scores for more important lesions, such as skin ulcers. The revised tool and
alternative scoring methods can be found at [insert website here].
Despite their similarities in performance in this study, the alternative scoring methods have
some practical advantages over the Original scoring method. The CAT has been criticized for
being overly long and complex. We have argued that this allows the CAT to be more
comprehensive and therefore to capture the full range of cutaneous disease in juvenile myositis
[3]. Given that our results here show that the alternative scoring methods perform similarly to
the Original method, maintenance of this complexity may be unnecessary. Both of the
alternative scoring methods convert the CAT to a simple 21-item scale, and eliminate the
gradations of severity originally described for each lesion. In doing so, the overall tool is
shortened and simplified, and can now be represented on a single page. This should increase
the acceptability of the CAT, likely decreasing administration time, and allowing it to be used
more widely in clinical and research contexts.
There is a potential limitation to the methods that we have used in this work. It is possible that
the 3 methods of scoring the CAT would have performed differently if they had actually been
administered to individual children with juvenile DM. For example, it is possible that a child
with very mild features of a particular lesion would be more likely to be scored as “absent”
using the Maximum method than with the Binary method because an assessor might be
reluctant to assign the “highest score” to a mild rash. We cannot determine if this was the case,
as this study only involved rescoring data that had previously been obtained.
In conclusion, we have compared 3 methods of scoring the CAT, and shown that these methods
perform similarly. Given that the alternative scoring methods allow the CAT to be shortened
and thus become more practical and more likely to be accepted by clinicians and researchers,
we recommend that an abbreviated form of the CAT be adopted. Future work will be needed
to ensure that the CAT continues to perform well in its new format.
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Table 1
Summary of baseline scores, inter-rater reliability, internal consistency and responsiveness for Original, Maximum
and Binary methods of scoring the CAT activity and damage scores.
Original Method Maximum Method Binary Method
Baseline CAT activity
score
Median 7 14 4
25th, 75th percentile 3, 11 6, 20 2, 5
Minimum, maximum 0, 44 0, 69 0, 12
Baseline CAT damage
score
Median 1 1 1
25th, 75th percentile 0, 1 0, 2 0, 1
Minimum, maximum 0, 13 0, 15 0, 8
Inter-rater reliability-
CAT activity score
Intraclass correlation coefficient 0.70 0.62 0.60
95% confidence interval 0.36, 0.86 0.28, 0.82 0.06, 0.83
Inter-rater reliability-
CAT damage score
Intraclass correlation coefficient 0.80 0.83 0.65
95% confidence interval 0.52, 0.92 0.65, 0.92 0.17, 0.85
Internal consistency-
CAT activity score
Cronbach’s alpha 0.79 0.76 0.76
95% confidence interval 0.74, 0.85 0.69, 0.82 0.69, 0.82
Minimum, maximum (serial item
deletion)*
0.76, 0.81 0.73, 0.77 0.73, 0.77
Internal consistency-
CAT damage score
Cronbach’s alpha 0.74 0.70 0.70
95% confidence interval 0.42, 1.0 0.41, 0.99 0.41, 0.99
Minimum, maximum (serial item
deletion)*
0.67, 0.76 0.61, 0.73 0.61, 0.73
Responsiveness-
CAT activity score
Standardized response mean 0.52 0.49 0.67
95% confidence interval 0.32, 0.72 0.29, 0.69 0.47, 0.87
Responsiveness-
CAT damage score
Standardized response mean 0.02 0.02 0.16
95% confidence interval −0.18, 0.22 −0.18, 0.22 −0.04, 0.36
*
This is the minimum and maximum values of Cronbach’s alpha that were obtained when each item was serially deleted from the calculation of the total
score.
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Table 2
Summary of the comparison of the construct validity of the 3 methods of scoring the Cutaneous Assessment
Tool (CAT)
Construct validity was assessed using Spearman’s rank correlations of the CAT activity and damage scores with other
measures of disease activity and damage. All P < 0.0001 except as noted.
CAT activity score
N OSM MSM BSM
Physician Global Assessment of Skin Disease Activity 96 0.83 0.81 0.81
Physician Global Assessment of Disease Activity 98 0.77 0.75 0.76
Childhood Myositis Assessment Scale 98 − 0.48 − 0.46 − 0.47
Childhood Health Assessment Scale 96 0.40 0.40 0.42
Total Manual Muscle Testing Score 50 − 0.36* − 0.39* − 0.40*
CAT damage score
OSM MSM BSM
Physician Global Assessment of Skin Disease Damage 95 0.53 0.54 0.49
Physician Global Assessment of Disease Damage 113 0.52 0.51 0.47
Childhood Myositis Assessment Scale 98 − 0.19† − 0.18† − 0.18†
Childhood Health Assessment Scale 96 0.13† 0.15† 0.11†
Total Manual Muscle Testing Score 50 − 0.38* − 0.34* − 0.37*
*
P ≥0.0001 and < 0.05
†
P ≥ 0.05
Abbreviations: OSM=Original scoring method, MSM=Maximum scoring method, BSM=Binary scoring method
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